31.35USD-2.12%Mkt Cap: 1.28B $P/E: 9.281d ago
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an ora…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap1.28B $
Enterprise Value399.35M $
Revenue (TTM)120.15M $
Gross Profit31.77M $
Net Income (TTM)-932.00K $
Revenue/Share22.20 USD
Last Price31.35 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)9.28
P/E (Forward)—
PEG—
EV/EBITDA9.65
EV/Revenue3.32
P/S9.46
P/B-0.53
EPS (TTM)3.14
EPS (Forward)—
52W Range
16.1282% of range34.74
52W High34.74 USD
52W Low16.12 USD
Profitability
Gross Margin82.60%
Oper. Margin80.23%
EBITDA Margin34.43%
Profit Margin-2.42%
ROE0.25%
ROA-1.28%
Growth
Revenue Growth2608.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.83M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-7.54M $
Net Debt/EBITDA-0.18
Balance Sheet
Debt/Equity-0.11
Current Ratio1.91
Quick Ratio1.17
Book Value/Sh-53.9460 USD
Cash/Share8.317 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.39.82M
Float2.64M
Insiders37.23%
Institutions18.86%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short0
Technical
SMA 5028.14 (+11.4%)
SMA 20028.14 (+11.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)632.05K
Avg Vol (10d)382.08K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—